APRE

APREA THERAPEUTICS INC

APRE·03836J201·US·Common Stock·Healthcare - Biotechnology-13D/G

APRE (APREA THERAPEUTICS INC) is held by 19 institutional investors as of Q2 2026. Largest holders: RENAISSANCE TECHNOLOGIES LLC ($84,883), GEODE CAPITAL MANAGEMENT, LLC ($60,072), CITADEL ADVISORS LLC ($47,015). Net institutional sentiment: Bullish.

19
Holders
$376,578
Total Value
73% (15)
Consensus
11 buying - 4 selling
13F: Insider & Congress: Updated regularly
APRE

Smart Money Verdict

View all
Loading verdict
Held by 19 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Dec 11, 2025 · Activists Aug 13, 2026 · Congress none

ActivistLLLYTTON LAURENCE W3.2%Aug 13, 2026
ActivistVPVestal Point Capital, LP9.9%May 15, 2026
ActivistNANantahala Capital Management, LLC4.5%Feb 13, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
105,800(+321.5%)$84,8830.0%+20.48%
35
Decreased
74,869(-37.1%)$60,0720.0%-44.72%
0
New
58,600$47,0150.0%+22.19%
31
Increased
45,211(+13.6%)$36,2730.0%-41.85%
15
Unchanged
38,464$30,8480.0%+15.29%
0
Increased
34,939(+168.4%)$28,0320.0%+19.53%
21
Increased
25,830(+15.7%)$20,7230.0%-56.64%
15
Increased
22,882(+16.6%)$18,3510.0%+16.22%
15
Decreased
16,052(-23.8%)$12,8790.0%-59.51%
0
Unchanged
13,864$11,1230.0%-85.35%
0
New
13,705$10,9960.0%+22.19%
26
New
10,565$8,4760.0%+22.19%
23
Decreased
7,173(-15.7%)$5,7550.0%-71.84%
0
Unchanged
577$4630.0%-98.62%
0
New
473$3790.0%+22.19%
17
Unchanged
295$2360.0%-77.30%
0
New
45$360.0%+22.19%
17
New
46$360.0%+22.19%
17
Decreased
3(-99.9%)$20.0%+9.89%
0
APREAPREAPREA THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used